Related Experiment Video

Updated: Sep 23, 2026

A Melanoma Patient-Derived Xenograft Model
07:07

A Melanoma Patient-Derived Xenograft Model

Published on: May 20, 2019

[Gene therapy of melanoma: review of published clinical trials]

N Penel1, J Bonneterre

  • 1Département de cancérologie générale, centre Oscar-Lambret, 3, rue F.-Combemale, 59020 cedex, Lille, France. n-penel@o-lambert.fr <n-penel@o-lambert.fr>

La Revue De Medecine Interne
|June 28, 2003
PubMed
Abstract

Insights

Gene therapy shows promise for metastatic melanoma, with 8% overall response rates in clinical trials. Further studies are underway to explore its potential against this increasing cancer frequency.

Area of Science:

  • Oncology
  • Gene Therapy
  • Melanoma Research

Context:

  • Increasing incidence of melanoma.
  • Limitations of conventional antitumoral treatments.
  • Emergence of gene therapy as a therapeutic strategy.

Purpose:

  • To review gene therapy clinical trials for metastatic melanoma.
  • To assess the efficacy and safety of gene therapy in melanoma treatment.

Summary:

  • Seventeen Phase I-II clinical trials investigated gene therapy for metastatic melanoma.
  • Sixteen trials utilized cytokine genes, exhibiting methodological heterogeneity.
  • Observed overall response rate of 8%, including complete histological responses.
  • Clinical tolerance was acceptable, with safety rarely discussed.

Impact:

  • Gene therapy offers a potential new avenue for metastatic melanoma treatment.
  • Highlights the need for standardized methodologies and safety discussions in gene therapy trials.
  • Indicates ongoing research with three new studies initiated in the US.

More Related Videos

A 3D Organotypic Melanoma Spheroid Skin Model08:49

A 3D Organotypic Melanoma Spheroid Skin Model

Published on: May 18, 2018

Experimental Melanoma Immunotherapy Model Using Tumor Vaccination with a Hematopoietic Cytokine09:15

Experimental Melanoma Immunotherapy Model Using Tumor Vaccination with a Hematopoietic Cytokine

Published on: February 24, 2023

Related Concept Videos

Tumor Immunotherapy01:27

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Gene Therapy01:22

Gene Therapy

Gene therapy is a technique where a gene is inserted into a person’s cells to prevent or treat a serious disease. The added gene may be a healthy version of the gene that is mutated in the patient, or it could be a different gene that inactivates or compensates for the patient’s disease-causing gene. For example, in patients with severe combined immunodeficiency (SCID) due to a mutation in the gene for the enzyme adenosine deaminase, a functioning version of the gene can be inserted. The...
Cancer Therapies02:49

Cancer Therapies

Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
Combination Therapies and Personalized Medicine02:50

Combination Therapies and Personalized Medicine

Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...